WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New DDDs 2020

ATC codeATC level name New DDD
A04AD11nabilone3mgO
A10BJ06semaglutide0.11mgP
A16AB17cerliponase alfa21mgP
A16AX09glycerol phenylbutyrate15gO
G03XX01prasterone6.5 mgV
G04BX15pentosan polysulfate sodium0.3gO
J01AA14sarecycline0.1 gO
J01AA15omadacycline0.3 g O
J01AA15omadacycline0.1gP
J01DD64cefpodoxime and beta-lactamase inhibitor0.4 1)gO
J01MA12levofloxacin0.24gInhal.solution
J04AA03calcium aminosalicylate15gO
J04AB06enviomycin1gP
J05AB03vidarabine0.7gP
J05AG06doravirine0.1gO
J05AH03peramivir0.6gP
J05AH04laninamivir40mgInhal.powder
J05AP06asunaprevir0.2gO
J05AP10elbasvir50mgO
J05AP11grazoprevir0.1gO
J05AX25baloxavir marboxil40mgO
J05AX26amenamevir0.4gO
J05AX27favipiravir1.6gO
L02BB05apalutamide0.24gO
L04AB07opinercept7mgP
L04AC12brodalumab15mgP
M03BX03pridinol6mgO
M04AB05lesinurad0.2gO
N02CD01 2)erenumab2.5mgP
N02CD02 3)galcanezumab4mgP
N02CD03fremanezumab7.5mgP
P01CA03fexinidazole1.44gO
V03AE10sodium zirconium cyclosilicate7.5gO
1) Refers to cefpodoxime
2) Previous ATC code N02CX07, new ATC 4th level N02CD valid from January 2020
3) Previous ATC code N02CX08, new ATC 4th level N02CD valid from January 2020.

Last updated: 2019-12-13